| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |